In the following a surprising effect of light upon the retina of albino and pigmented rats will be described. It was discovered when “normal” unanesthetized and unrestrained rats were maintained continuously for 24 hours in an environment illuminated by ordinary fluorescent light bulbs.—Noell et al., 1966
Paracelsus, the medieval alchemist and physician, noted that it is the dose of a substance that renders it a poison or a remedy. This is also true of light, which obviously is essential for most life on earth, but in an overdose, can threaten the health of vision.
Such an overdose was observed in the seminal studies of Noell et al.
1 on damage caused by “normal” laboratory lights in the rat, a nocturnal species. The human visual system can adapt to an illuminance range of 10 to 11 log units. Why then should the human retina be endangered by light? However, epidemiologic studies and numerous case reports demonstrate that light can indeed injure the human retina (for a review, see Ref.
2 ).
Light damage and retinal degenerative diseases in humans and in animal models have an important feature in common: cell loss by apoptosis of photoreceptors and pigment epithelium (PE).
2 3 4 5 This crucial feature may render light damage a suitable model system to investigate cellular and molecular mechanisms of apoptosis with the aim of understanding and eventually treating or preventing, if only in part, retinal degenerative diseases in humans.
There are several model systems suitable for the investigation of cellular and molecular mechanisms of light-induced damage to the retina:
-
Chronic, low-level exposure in the range of weeks to white fluorescent light in unrestrained animals.
-
Acute high-level exposure in the range of 30 minutes to several hours to white fluorescent light in unrestrained animals.
-
Spectral exposures in the range of 1 to 30 minutes to light of defined wavelengths, in unrestrained or restrained animals.
In our laboratory, we use acute, short-term exposure of unrestrained mice and rats to high levels of white fluorescent light and acute exposure of anesthetized mice and rats to defined wavelengths (blue and green).
Possible Links of Apoptosis to Intracellular Degradation: Autophagy, Lysosomes, and Proteasomes
Many models are born with the “genetic defect” of limited applicability to human disease. An obvious but unavoidable obstacle is the fact that hardly any animal model reaches the lifespan of humans. Thus, this very simple condition enables many more environmental stress factors to interact with different genes or affect directly the human eye than can ever be simulated in the long term in animal models. Animal models, therefore, often have to be manipulated in a time-lapse fashion. This manipulation is essentially what our laboratory has developed with short-term high illuminance levels to induce apoptosis. This model has the advantage of synchronized cell death and, therefore, an easier way to interact with apoptosis. Furthermore, short-term exposures to light reduce the probability of masking by secondary phenomena after the initial event of cell death. The knowledge from this artificial situation does help in the study of how the apoptotic machinery works in the retina and which rescue strategies are effective. With this gain, we can then move to animal models of retinal degenerations and analyze differences and commonalities of both conditions.
An essential difference between light- and mutation-induced apoptosis needs consideration in the context of cell rescue. Light evokes apoptosis in an otherwise healthy cell, and rescue would restore this health. This is in contrast to mutation-induced apoptosis, in which abnormal proteins are synthesized from birth, and rescue may prevent cell death, but in most cases does not repair the metabolic defect resulting from the mutation. Nevertheless, there are several animal models in which rescue works in both light-damage–and mutation-induced apoptosis, perhaps indicating similar mechanisms of apoptosis.
5
Apart from representing a model system, light-induced apoptosis is directly linked to human life. Light-induced retinopathies are observed in the clinic and the laboratory, and findings in epidemiologic studies have suggested that exposure to light can contribute to AMD. Therefore, the development of preventive measures is important, as is the elucidation of pathogenic mechanisms through which light promotes retinal degenerations.
Supported by Swiss National Science Foundation, the German Research Council and numerous private foundations in Switzerland and Germany.
Disclosure:
C.E. Remé, None
Corresponding author: Charlotte E. Remé, Department of Ophthalmology, University Hospital, 8091 Zurich, Switzerland;
chreme@opht.unizh.ch.
My very sincere and wholehearted thanks go to ARVO—the Awards Committee, the Board of Trustees, and the society as a whole—for bestowing this great honor on me.
Special thanks go to my friend and colleague François Delori for introducing me in such an elegant and humorous way; to Christian Grimm and Andreas Wenzel for being my innovative, gifted, and loyal colleagues in the laboratory; and to Farhad Hafezi for having been an original and loyal coworker while he was a postdoctoral fellow in our laboratory.
I will always appreciate past and present collaborators for essential input in our work: Anna Wirz-Justice, Michael and Jiuan Terman, Gunter Niemeyer, Armand Malnoe, Joseph Pfeilschifter, Graig Eldred, Pascal Rol, Andreas Marti, Jim Dillon, and Uwe Wolfrum, Edward N. Pugh, and Trevor Lamb.
Our group owes fruitful collaborations to Matthias Seeliger, Eberhard Zrenner, Deborah Farber, Don Fox, Michael Redmond, Michael Danciger, Pete Humphries, Janis Lem, Martin Obin, Christoph Richter, Mel Simon, Wolfgang Berger, Françis Munier, Ivan Arsenijevic, John Crabb, Theo van Veen, Elisabeth Rungger, Rex Martin, members of the program “age-related macular degeneration” of the German Research Council.
Several postdoctoral fellows and visiting scientists did great work in our laboratory: Thomas Hoppeler, Philip Hendrikson, Enrica Strettoi, Eveline Federspiel, Ursula Urner, Hans Jung, Urs Braschler, Ron Bush, Jörg Reinboth, Matthias Clausen, Marijana Samardzia, Charlotte Keller, Rico Frigg, and Hans-Peter Iseli.
Our work over many years could not have been done without the excellent technical help of Maja Sulser, Sylvia Hoffmann, Esther Bossuge, Barbara Aeberhard, Astrid Rhyner, Kurt Munz, Cornelia Imsand, Gabi Hoegger, and Dora Greuter.
Among colleagues, there are my friends Dan Organisciak and Barry Winkler, with whom I shared many stimulating and refreshing conversations and hearty laughs. Highly respected and longstanding colleagues are Alan Bird, Dean Bok, Matt LaVail, Gene Anderson, and Joe Hollyfield.
I will never forget Ted Williams, not only as the man who, among many other skills, taught us to count photons, but also as an amiable, generous, and gentle friend, and his widow Ruth Anne, for years of warm and lively friendship.
Throughout life, it was not easy to become a reasonable human being. Without the help of my parents and my partner Heinrich Schmid, I would not have made it.
A similarly long distance on the road of professional life could not have been covered without my great mentor Richard W. Young, who introduced me to the world of visual cells and provided vital encouragement to go ahead in science. Rudolf Witmer was a pioneer in founding a research laboratory within a clinical setting. He helped in my decision to move from clinical work to research and was my role model for generosity and tolerance as head of the Ophthalmology Department in Zurich. Balder Gloor, as subsequent head of the Department of Ophthalmology, essentially facilitated and continuously encouraged the growth of our laboratory and my professional career.
I thank Christina Fasser, president of Retina International and Retina Suisse, for many years of friendship. It is with great and unceasing admiration that I regard her and the incredible courage and good spirit she demands of herself day after day and passes on to her fellow beings.
Last but not least, I thank the Swiss National Science Foundation, the German Research Council and numerous private foundations in Switzerland and Germany for continuous and essential support of our work.
NoellWK, WalkerVS, KangBS, BermanS. Retinal damage by light in rats. Invest Ophthalmol. 1966;5:450–473.
[PubMed]ReméCE, HafeziF, MartiA, MunzK, ReinbothJJ. Light damage to retina and pigment epithelium.MarmorMF WolfensbergerTJ eds. The Retinal Pigment Epithelium: Function and Disease. 1998;568–586.Oxford University Press New York.
Portera-CailliauC, SungCH, NathansJ, AdlerR. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA. 1994;91:974–978.
[CrossRef] [PubMed]ReméCE, GrimmC, HafeziF, MartiA, WenzelA. Apoptotic cell death in retinal degenerations. Prog Retin Eye Res. 1998;17:443–464.
[CrossRef] [PubMed]WenzelA, GrimmC, ReméCE. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res. 2005;24:275–306.
[CrossRef] [PubMed]YoungRW. Visual cells and the concept of renewal. Invest Ophthalmol Vis Sci. 1976;15:700–725.
[PubMed]SzczesnyPJ, MunzK, ReméCE. Light damage in the rat retina: patterns of acute lesions and recovery.PleyerU ThielHJ eds. Cell and Tissue Protection in Ophthalmology. 1995;163–175.Hippokrates Stuttgart, Germany.
EldredGE, LaskyMR. Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature. 1993;361:724–726.
[CrossRef] [PubMed]LiuJ, ItagakiY, Ben-ShabatS, NakanishiK, SparrowJR. The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J Biol Chem. 2000;275:29354–29360.
[CrossRef] [PubMed]FishkinN, JangYP, ItagakiY, SparrowJR, NakanishiK. A2-rhodopsin: a new fluorophore isolated from photoreceptor outer segments. Org Biomol Chem. 2003;1:1101–1105.
[CrossRef] [PubMed]RedmondTM, YuS, LeeE, et al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet. 1998;20:344–351.
[CrossRef] [PubMed]GrimmC, WenzelA, HafeziF, et al. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat Genet. 2000;25:63–66.
[CrossRef] [PubMed]BushRA, ReméCE, MalnoeA. Light damage in the rat retina: the effect of dietary deprivation of N-3 fatty acids on acute structural alterations. Exp Eye Res. 1991;53:741–752.
[CrossRef] [PubMed]BushRA, MalnoeA, ReméCE, WilliamsTP. Dietary deficiency of N-3 fatty acids alters rhodopsin content and function in the rat retina. Invest Ophthalmol Vis Sci. 1994;35:91–100.
[PubMed]ReméCE, MalnoeA, JungHH, WeiQ, MunzK. Effect of dietary fish oil on acute light-induced photoreceptor damage in the rat retina. Invest Ophthalmol Vis Sci. 1994;35:78–90.
[PubMed]LaVailMM, GorrinGM, RepaciMA, ThomasLA, GinsbergHM. Genetic regulation of light damage to photoreceptors. Invest Ophthalmol Vis Sci. 1987;28:1043–1048.
[PubMed]DancigerM, MatthesMT, YasamuraD, et al. A QTL on distal chromosome 3 that influences the severity of light-induced damage to mouse photoreceptors. Mamm Genome. 2000;11:422–427.
[CrossRef] [PubMed]WenzelA, ReméCE, WilliamsTP, HafeziF, GrimmC. The Rpe65 Leu450Met variation increases retinal resistance against light-induced degeneration by slowing rhodopsin regeneration. J Neurosci. 2001;21:53–58.
[PubMed]GollapalliDR, MaitiP, RandoRR. RPE65 operates in the vertebrate visual cycle by stereospecifically binding all-trans-retinyl esters. Biochemistry. 2003;42:11824–11830.
[CrossRef] [PubMed]KimSR, FishkinN, KongJ, et al. Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. Proc Natl Acad Sci USA. 2004;101:11668–11672.
[CrossRef] [PubMed]IseliHP, WenzelA, HafeziF, ReméCE, GrimmC. Light damage susceptibility and RPE65 in rats. Exp Eye Res. 2002;75:407–413.
[CrossRef] [PubMed]BeatriceJ, WenzelA, ReméCE, GrimmC. Increased light damage susceptibility at night does not correlate with RPE65 levels and rhodopsin regeneration in rats. Exp Eye Res. 2003;76:695–700.
[CrossRef] [PubMed]PennJS, AndersonRE. Effect of light history on rod outer-segment membrane composition in the rat. Exp Eye Res. 1987;44:767–778.
[CrossRef] [PubMed]PennJS, NaashMI, AndersonRE. Effect of light history on retinal antioxidants and light damage susceptibility in the rat. Exp Eye Res. 1987;44:779–788.
[CrossRef] [PubMed]OrganisciakDT, DarrowRM, BarsalouL, KuttyRK, WiggertB. Circadian-dependent retinal light damage in rats. Invest Ophthalmol Vis Sci. 2000;41:3694–3701.
[PubMed]IshizawaY, SharpR, LiebmanPA, EckenhoffRG. Halothane binding to a G protein coupled receptor in retinal membranes by photoaffinity labeling. Biochemistry. 2000;39:8497–8502.
[CrossRef] [PubMed]KellerC, GrimmC, WenzelA, HafeziF, ReméCE. Protective effect of halothane anesthesia on retinal light damage: inhibition of metabolic rhodopsin regeneration. Invest Ophthalmol Vis Sci. 2001;42:476–480.
[PubMed]SievingPA, ChaudhryP, KondoM, et al. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci USA. 2001;98:1835–1840.
[CrossRef] [PubMed]GollapalliDR, RandoRR. The specific binding of retinoic acid to RPE65 and approaches to the treatment of macular degeneration. Proc Natl Acad Sci USA. 2004;101:10030–10035.
[CrossRef] [PubMed]LambTD, PughEN, Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004;23:307–380.
[CrossRef] [PubMed]HaoW, WenzelA, ObinMS, et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet. 2002;32:254–260.
[CrossRef] [PubMed]MorganJI, CurranT. Immediate-early genes: ten years on. Trends Neurosci. 1995;18:66–67.
[CrossRef] [PubMed]SmeyneRJ, VendrellM, HaywardM, et al. Continuous c-fos expression precedes programmed cell death in vivo. Nature. 1993;363:166–169.
[CrossRef] [PubMed]ShaulianE, KarinM. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131–E136.
[CrossRef] [PubMed]NirI, AgarwalN. Diurnal expression of c-fos in the mouse retina. Brain Res Mol Brain Res. 1993;19:47–54.
[CrossRef] [PubMed]AroninN, SagarSM, SharpFR, SchwartzWJ. Light regulates expression of a Fos-related protein in rat suprachiasmatic nuclei. Proc Natl Acad Sci USA. 1990;87:5959–5962.
[CrossRef] [PubMed]RichKA, ZhanY, BlanksJC. Aberrant expression of c-Fos accompanies photoreceptor cell death in the rd mouse. J Neurobiol. 1997;32:593–612.
[CrossRef] [PubMed]HafeziF, SteinbachJP, MartiA, et al. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat Med. 1997;3:346–349.
[CrossRef] [PubMed]WenzelA, IseliHP, FleischmannA, et al. Fra-1 substitutes for c-Fos in AP-1-mediated signal transduction in retinal apoptosis. J Neurochem. 2002;80:1089–1094.
[CrossRef] [PubMed]WenzelA, GrimmC, SamardzijaM, ReméCE. The genetic modifier Rpe65Leu(450): effect on light damage susceptibility in c-Fos-deficient mice. Invest Ophthalmol Vis Sci. 2003;44:2798–2802.
[CrossRef] [PubMed]FleischmannA, HafeziF, ElliottC, et al. Fra-1 replaces c-Fos-dependent functions in mice. Genes Dev. 2000;14:2695–2700.
[CrossRef] [PubMed]HafeziF, AbeggM, GrimmC, et al. Retinal degeneration in the rd mouse in the absence of c-fos. Invest Ophthalmol Vis Sci. 1998;39:2239–2244.
[PubMed]WenzelA, GrimmC, SeeligerMW, et al. Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci. 2001;42:1653–1659.
[PubMed]HerrlichP. Cross-talk between glucocorticoid receptor and AP-1. Oncogene. 2001;20:2465–2475.
[CrossRef] [PubMed]WenzelA, GrimmC, MartiA, et al. c-fos controls the “private pathway” of light-induced apoptosis of retinal photoreceptors. J Neurosci. 2000;20:81–88.
[PubMed]SperlingHG. Spectral sensitivity, intense spectral light studies and the color receptor mosaic of primates. Vision Res. 1986;26:1557–1571.
[CrossRef] [PubMed]van NorrenD, SchellekensP. Blue light hazard in rat. Vision Res. 1990;30:1517–1520.
[CrossRef] [PubMed]SparrowJR, NakanishiK, ParishCA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:1981–1989.
[PubMed]MargrainTH, BoultonM, MarshallJ, SlineyDH. Do blue light filters confer protection against age-related macular degeneration?. Prog Retin Eye Res. 2004;23:523–531.
[CrossRef] [PubMed]GrimmC, ReméCE, RolPO, WilliamsTP. Blue light’s effects on rhodopsin: photoreversal of bleaching in living rat eyes. Invest Ophthalmol Vis Sci. 2000;41:3984–3990.
[PubMed]GrimmC, WenzelA, WilliamsT, et al. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest Ophthalmol Vis Sci. 2001;42:497–505.
[PubMed]BartlFJ, RitterE, HofmannKP. Signaling states of rhodopsin: absorption of light in active metarhodopsin II generates an all-trans-retinal bound inactive state. J Biol Chem. 2001;276:30161–30166.
[CrossRef] [PubMed]WilliamsTP. Photolysis of metarhodopsin II. Rates of production of P470 and rhodopsin. Vision Res. 1968;8:1457–1466.
[CrossRef] [PubMed]MataNL, WengJ, TravisGH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci USA. 2000;97:7154–7159.
[CrossRef] [PubMed]SuterM, ReméCE, GrimmC, et al. Age-related macular degeneration: the lipofusin component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem. 2000;275:39625–39630.
[CrossRef] [PubMed]BergmannM, SchuttF, HolzFG, KopitzJ. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 2004;18:562–564.
[PubMed]GaillardER, AvalleLB, KellerLM, et al. A mechanistic study of the photooxidation of A2E, a component of human retinal lipofuscin. Exp Eye Res. 2004;79:313–319.
[CrossRef] [PubMed]FriedmanJ, XueD. To live or die by the sword: the regulation of apoptosis by the proteasome. Dev Cell. 2004;6:460–461.
[CrossRef] [PubMed]JohnsonDE. Noncaspase proteases in apoptosis. Leukemia. 2000;14:1695–1703.
[CrossRef] [PubMed]SchlegelRA, WilliamsonP. Phosphatidylserine, a death knell. Cell Death Differ. 2001;8:551–563.
[CrossRef] [PubMed]WyllieAH, GolsteinP. More than one way to go. Proc Natl Acad Sci USA. 2001;98:11–13.
[CrossRef] [PubMed]SyntichakiP, TavernarakisN. The biochemistry of neuronal necrosis: rogue biology?. Nat Rev Neurosci. 2003;4:672–684.
[PubMed]StokaV, TurkB, SchendelSL, et al. Lysosomal protease pathways to apoptosis: cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem. 2001;276:3149–3157.
[CrossRef] [PubMed]GuicciardiME, LeistM, GoresGJ. Lysosomes in cell death. Oncogene. 2004;23:2881–2890.
[CrossRef] [PubMed]BurschW. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. 2001;8:569–581.
[CrossRef] [PubMed]XueL, FletcherGC, TolkovskyAM. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol Cell Neurosci. 1999;14:180–198.
[CrossRef] [PubMed]YanagisawaH, MiyashitaT, NakanoY, YamamotoD. HSpin1, a transmembrane protein interacting with Bcl-2/Bcl-xL, induces a caspase-independent autophagic cell death. Cell Death Differ. 2003;10:798–807.
[CrossRef] [PubMed]WojcikC. Regulation of apoptosis by the ubiquitin and proteasome pathway. J Cell Mol Med. 2002;6:25–48.
[CrossRef] [PubMed]JesenbergerV, JentschS. Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol. 2002;3:112–121.
[CrossRef] [PubMed]AbeliovichH, KlionskyDJ. Autophagy in yeast: mechanistic insights and physiological function. Microbiol Mol Biol Rev. 2001;65:463–479.
[CrossRef] [PubMed]MizushimaN, OhsumiY, YoshimoriT. Autophagosome formation in mammalian cells. Cell Struct Funct. 2002;27:421–429.
[CrossRef] [PubMed]KlionskyDJ, EmrSD. Autophagy as a regulated pathway of cellular degradation. Science. 2000;290:1717–1721.
[CrossRef] [PubMed]YuanJ, LipinskiM, DegterevA. Diversity in the mechanisms of neuronal cell death. Neuron. 2003;40:401–413.
[CrossRef] [PubMed]RemeC, Wirz-JusticeA, RhynerA, HofmannS. Circadian rhythm in the light response of rat retinal disk-shedding and autophagy. Brain Res. 1986;369:356–360.
[CrossRef] [PubMed]ReméCE, WolfrumU, ImsandC, HafeziF, WilliamsTP. Photoreceptor autophagy: effects of light history on number and opsin content of degradative vacuoles. Invest Ophthalmol Vis Sci. 1999;40:2398–2404.
[PubMed]NaashMI, Al-UbaidiMR, AndersonRE. Light exposure induces ubiquitin conjugation and degradation activities in the rat retina. Invest Ophthalmol Vis Sci. 1997;38:2344–2354.
[PubMed]ObinM, LeeBY, MeinkeG, et al. Ubiquitylation of the transducin betagamma subunit complex: regulation by phosducin. J Biol Chem. 2002;277:44566–44575.
[CrossRef] [PubMed]ShangF, TaylorA. Function of the ubiquitin proteolytic pathway in the eye. Exp Eye Res. 2004;78:1–14.
[CrossRef] [PubMed]LouieJL, KapphahnRJ, FerringtonDA. Proteasome function and protein oxidation in the aged retina. Exp Eye Res. 2002;75:271–284.
[CrossRef] [PubMed]IllingME, RajanRS, BenceNF, KopitoRR. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem. 2002;277:34150–34160.
[CrossRef] [PubMed]SalibaRS, MunroPM, LuthertPJ, CheethamME. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J Cell Sci. 2002;115:2907–2918.
[PubMed]ChuangJZ, VegaC, JunW, SungCH. Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes. J Clin Invest. 2004;114:131–140.
[CrossRef] [PubMed]NoorwezSM, MalhotraR, McDowellJH, et al. Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H. J Biol Chem. 2004;279:16278–16284.
[CrossRef] [PubMed]RossCA, PoirierMA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10:S10–S17.
[CrossRef] [PubMed]ChappleJP, GraysonC, HardcastleAJ, et al. Unfolding retinal dystrophies: a role for molecular chaperones?. Trends Mol Med. 2001;7:414–421.
[CrossRef] [PubMed]LiZ, ArnaudL, RockwellP, Figueiredo-PereiraME. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells. J Neurochem. 2004;90:19–28.
[CrossRef] [PubMed]GruneT, JungT, MerkerK, DaviesKJ. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and ‘aggresomes’ during oxidative stress, aging, and disease. Int J Biochem Cell Biol. 2004;36:2519–2530.
[CrossRef] [PubMed]OrganisciakDT, WinklerB. Retinal light damage: practical and theoretical considerations. Prog Retin Eye Res. 1994.1–29.
KopitoRR. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000;10:524–530.
[CrossRef] [PubMed]HanayamaR, TanakaM, MiyasakaK, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004;304:1147–1150.
[CrossRef] [PubMed]SavillJ, DransfieldI, GregoryC, HaslettC. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol. 2002;2:965–975.
[CrossRef] [PubMed]CrabbJW, MiyagiM, GuX, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA. 2002;99:14682–14687.
[CrossRef] [PubMed]HagemanGS, LuthertPJ, Victor ChongNH, et al. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705–732.
[CrossRef] [PubMed]PenfoldPL, MadiganMC, GilliesMC, ProvisJM. Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res. 2001;20:385–414.
[CrossRef] [PubMed]AndersonDH, MullinsRF, HagemanGS, JohnsonLV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411–431.
[CrossRef] [PubMed]AmbatiJ, AnandA, FernandezS, et al. An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med. 2003;9:1390–1397.
[CrossRef] [PubMed]HoppelerT, HendricksonP, DietrichC, ReméCE. Morphology and time-course of defined photochemical lesions in the rabbit retina. Curr Eye Res. 1988;7:849–860.
[CrossRef] [PubMed]JungH, ReméCE. Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, melitin and lithium. Graefes Arch Clin Exp Ophthalmol. 1994;232:167–175.
[CrossRef] [PubMed]ReinbothJJ, ClausenM, ReméCE. Light elicits the release of docosahexaenoic acid from membrane phospholipids in the rat retina in vitro. Exp Eye Res. 1996;63:277–284.
[CrossRef] [PubMed]